MATTHEW FINLEY: Open Payments
NPI 1972951622 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$95 in 6 payments from 6 companies in 2025. Trend: 2023 $29 · 2024 $33 · 2025 $95
Food & beverage: $95
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: REXULTI, JARDIANCE, TRELEGY ELLIPTA, Cologuard Collection Kit, Kerendia, CAPLYTA.
Industry payments across KY — which companies pay providers there.
